作者
Peter J Barnes
发表日期
2006/6
来源
British journal of pharmacology
卷号
148
期号
3
页码范围
245-254
出版商
Blackwell Publishing Ltd
简介
Corticosteroids are the most effective anti‐inflammatory therapy for many chronic inflammatory diseases, such as asthma but are relatively ineffective in other diseases such as chronic obstructive pulmonary disease (COPD). Chronic inflammation is characterised by the increased expression of multiple inflammatory genes that are regulated by proinflammatory transcription factors, such as nuclear factor‐kappaB and activator protein‐1, that bind to and activate coactivator molecules, which then acetylate core histones to switch on gene transcription. Corticosteroids suppress the multiple inflammatory genes that are activated in chronic inflammatory diseases, such as asthma, mainly by reversing histone acetylation of activated inflammatory genes through binding of liganded glucocorticoid receptors (GR) to coactivators and recruitment of histone deacetylase‐2 (HDAC2) to the activated transcription complex. At higher …
引用总数
200720082009201020112012201320142015201620172018201920202021202220232024395957585445555240576773556890816941